|
SMS Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2840.85 Cr.
|
P/BV
|
3.90
|
Book Value (Rs.)
|
82.21
|
|
52 Week High/Low (Rs.)
|
360/176
|
FV/ML
|
1/1
|
P/E(X)
|
41.09
|
|
Bookclosure
|
22/09/2025
|
EPS (Rs.)
|
7.80
|
Div Yield (%)
|
0.12
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 8.16 | 5.89 | -0.83 | 7.35 | 7.39 |
| Diluted EPS (Rs.) | 8.16 | 5.89 | -0.83 | 7.35 | 7.39 |
| Cash EPS (Rs.) | 11.48 | 9.54 | 4.25 | 11.82 | 9.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 72.15 | 63.36 | 54.40 | 55.56 | 48.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 72.15 | 63.36 | 54.40 | 55.56 | 48.50 |
| Revenue From Operations / Share (Rs.) | 88.29 | 83.79 | 61.67 | 61.41 | 66.53 |
| PBDIT / Share (Rs.) | 16.38 | 14.30 | 7.02 | 14.12 | 14.71 |
| PBIT / Share (Rs.) | 12.51 | 10.58 | 3.22 | 10.32 | 12.08 |
| PBT / Share (Rs.) | 10.42 | 7.81 | 0.63 | 8.09 | 10.76 |
| Net Profit / Share (Rs.) | 7.60 | 5.81 | 0.45 | 8.02 | 7.20 |
| NP After MI And SOA / Share (Rs.) | 7.80 | 5.89 | -0.83 | 7.35 | 7.39 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 18.55 | 17.07 | 11.37 | 22.99 | 22.11 |
| PBIT Margin (%) | 14.16 | 12.62 | 5.22 | 16.80 | 18.16 |
| PBT Margin (%) | 11.79 | 9.32 | 1.02 | 13.17 | 16.17 |
| Net Profit Margin (%) | 8.61 | 6.93 | 0.74 | 13.05 | 10.82 |
| NP After MI And SOA Margin (%) | 8.83 | 7.02 | -1.35 | 11.96 | 11.10 |
| Return on Networth / Equity (%) | 10.80 | 9.29 | -1.53 | 13.23 | 15.23 |
| Return on Capital Employeed (%) | 13.38 | 12.75 | 4.36 | 13.17 | 16.54 |
| Return On Assets (%) | 5.99 | 4.81 | -0.80 | 7.23 | 7.69 |
| Long Term Debt / Equity (X) | 0.21 | 0.22 | 0.26 | 0.31 | 0.36 |
| Total Debt / Equity (X) | 0.48 | 0.52 | 0.54 | 0.55 | 0.53 |
| Asset Turnover Ratio (%) | 0.71 | 0.74 | 0.60 | 0.61 | 0.78 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.72 | 1.62 | 1.61 | 1.92 | 1.59 |
| Quick Ratio (X) | 0.84 | 0.91 | 0.73 | 0.64 | 0.88 |
| Inventory Turnover Ratio (X) | 3.02 | 1.86 | 1.26 | 1.99 | 2.35 |
| Dividend Payout Ratio (NP) (%) | 4.89 | 5.09 | -35.97 | 4.08 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3.27 | 3.12 | 10.13 | 2.69 | 0.00 |
| Earning Retention Ratio (%) | 95.11 | 94.91 | 135.97 | 95.92 | 0.00 |
| Cash Earning Retention Ratio (%) | 96.73 | 96.88 | 89.87 | 97.31 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 7.83 | 5.16 | 2.71 | 6.33 | 11.16 |
| Interest Coverage Ratio (Post Tax) (%) | 4.64 | 3.10 | 1.18 | 4.60 | 6.46 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 2151.85 | 1748.52 | 734.33 | 1007.49 | 1231.25 |
| EV / Net Operating Revenue (X) | 2.75 | 2.47 | 1.41 | 1.94 | 2.19 |
| EV / EBITDA (X) | 14.82 | 14.44 | 12.36 | 8.43 | 9.88 |
| MarketCap / Net Operating Revenue (X) | 2.41 | 2.13 | 0.93 | 1.53 | 1.87 |
| Retention Ratios (%) | 95.10 | 94.90 | 135.97 | 95.91 | 0.00 |
| Price / BV (X) | 2.95 | 2.81 | 1.06 | 1.69 | 2.57 |
| Price / Net Operating Revenue (X) | 2.41 | 2.13 | 0.93 | 1.53 | 1.87 |
| EarningsYield | 0.03 | 0.03 | -0.01 | 0.07 | 0.05 |
